Hilltelligence markHilltelligence
Bills/H.R. 1843119th Congress

To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

House: Referred
Companion bill: S. 891(Related bill)
Cosponsors
1
Introduced
2025-03-05
Last action
2025-03-05

Referred to the House Committee on Energy and Commerce.

Sign in to view Hilltelligence’s plain-English summary.

Action Timeline
  1. HouseLatest

    Referred to the House Committee on Energy and Commerce.

  2. House

    Introduced in House

Sign in to view Hilltelligence’s passage-probability analysis.

Official Sources
Topics

Policy area

Health

Sign in to view Hilltelligence’s potential-cosponsor analysis.